How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?

Phase 4

Terminated

• Conditions: Glaucoma, Open-Angle; Glaucoma; Drugs

• Registration Number: NCT06369077
• Lead Sponsor: CT Glaucoma Associates

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-4-12
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Terminated
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - Adult glaucoma patients who are taking drops: dor-tim and Latanoprost Ophthalmic<br> Solution 0.005% (Lat) and come in for an appointment during the trial period<br><br>Exclusion Criteria:<br><br> - Patients who had an SLT or glaucoma procedure or surgery within 3 months of<br> enrollment will be excluded. Other exclusion criteria include the logistical<br> inability to follow up with the trial, the inability to relax eye muscles for an<br> accurate tonometry measurement, and the inability to instill medications.<br><br>The final determination to be included in the study will be made by the Physician on the<br>day of the appointment.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
intraocular pressure

Secondary Outcome Measures

Name	Time	Method
dry eye